CONMED Corp — Director's Dealing 2014

Aug 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-08-11

Reporting Person: SHALLISH ROBERT D JR (EVP, Finance, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-11	Common Stock	M	10000	$26.69	Acquired	59059	Direct
2014-08-11	Common Stock	F	8220	$37.00	Disposed	50839	Direct
2014-08-11	Common Stock	M	2000	$16.46	Acquired	52839	Direct
2014-08-11	Common Stock	F	1291	$37.00	Disposed	51548	Direct
2014-08-11	Common Stock	M	2800	$19.26	Acquired	54348	Direct
2014-08-11	Common Stock	F	1943	$37.00	Disposed	52405	Direct
2014-08-11	Common Stock	M	2800	$26.09	Acquired	55205	Direct
2014-08-11	Common Stock	F	2273	$37.00	Disposed	52932	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-11	Sars (Stock Appreciation Rights)	$26.69	M	10000	Disposed	2018-06-01	Common Stock (10000)	Direct
2014-08-11	Sars (Stock Appreciation Rights)	$16.46	M	2000	Disposed	2019-06-01	Common Stock (2000)	Direct
2014-08-11	Sars (Stock Appreciation Rights)	$19.26	M	2800	Disposed	2020-06-01	Common Stock (2800)	Direct
2014-08-11	Sars (Stock Appreciation Rights)	$26.09	M	2800	Disposed	2022-06-01	Common Stock (2800)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.